Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 3Phase 1/2 2Phase 4 1

Status

Completed 24Unknown 21Not yet recruiting 6Recruiting 5Terminated 2Active not recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 2Stomach Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pneumonia 1Neoplasms 1Lung Diseases, Interstitial 1Infertility 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1Adenocarcinoma Of Esophagus 1

Interventions

Surgical Procedures, Operative 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Suspended × Stomach Neoplasms × Clear all
NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

University of Chicago

Phase 4 Suspended
36 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡